»
Biochemical Pharmacology
 
 

Biochemical Pharmacology

 
 

Journal

 4.576(2012)

4.529

Editor-in-Chief::S.J. Enna

Show

00062952

87-92

24

Go to Journal Website

Print Journal

Subscription Details

Estimated Delivery Time


In Stock

USD 10,550.00
Terms & Conditions

Additional Subscription Help

 
 
 

Aims & Scope

Biochemical Pharmacology is devoted to publishing original work on the pharmacodynamics and pharmacokinetics of drugs and nontherapeutic xenobiotics. Its audience are scientists engaged in drug discovery and in identifying drug mechanisms of action. All areas of pharmacology are represented in the journal, including drug metabolism and kinetics. It is of particular value to those interested in anti-inflammatory drugs, cancer chemotherapy, neuropharmacology and cardiovascular pharmacology.
While particular emphasis is placed on reporting findings that relate to the actions and metabolism of drugs and toxic substances at the biochemical and molecular levels, submissions in the areas of behavioral and physiological pharmacology and toxicology are also encouraged if they describe studies directed at defining mechanisms of action.
Reports based on experiments conducted with mixtures, plant or animal extracts will not be considered for publication unless the chemical structures and concentrations of all substances are known and the compounds are obtained from commercial suppliers.

The journal publishes the following types of reports:
(1) Full-length Research Papers. These contain the results of original research on an issue of relevance to the field of pharmacology.
(2) Commentaries. These are commissioned articles that provide the author's view on a selected topic of interest to pharmacologists.

US National Institutes of Health (NIH) voluntary posting ("Public Access") policy
Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy.

Please bookmark this URL: http://www.elsevier.com/locate/biochempharm

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: click here

Audience

Pharmacologists, Biochemists, Toxicologists, Neuroscientists, Molecular and Cellular Biologists.

Abstracting and Indexing

BIOSIS, Chemical Abstracts, Current Contents/ASCA, Current Contents/BIOMED Database, Current Contents/Life Sciences, Current Contents/SciSearch Database, Current Contents/Science Citation Index, EMBASE, Elsevier BIOBASE, MEDLINE®, PASCAL/CNRS, Reference Update, Scopus
Editor-in-Chief: S.J. Enna University of Kansas Medical Center, Kansas City, KS, USA, Editors: J.G. Piette Université de Liège, Liège, Belgium, K. Mullane Profectus Pharma Consulting, Inc., San Jose, CA, USA, Commentary Editor: M. Williams Northwestern University, lake Forest, IL, USA, Editorial Office: Biochemical Pharmacology University of Kansas Medical Center, 3901 Rainbow Boulevard, Mail Stop 4016, Kansas City, KS 66160, USA, Fax: +1-913-588-7373, Managing Editor: L. LeCount , Editorial Coordinator: C. Martin , Editorial Advisory Board , Antibiotics and Chemotherapeutics B.B. Aggarwal University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA, R. Alfieri University of Parma, Parma, Italy, C. Bailly Institut de Recherche Pierre Fabre, Toulouse, France, E. A. Bey West Virginia University, Morgantown, WV, USA, S. Ceruti Università degli Studi di Milano, Milano, Italy, B.S. Cummings University of Georgia, Athens, GA, USA, M. Davies University of Texas M.D. Anderson Cancer Center, Houston, TX, USA, E. De Clercq KU Leuven, Leuven, Belgium, M. Diederich Cancer and Blood Disease Research Foundation, Luxembourg, Luxembourg, J.-D. Docquier Università degli Studi di Siena, Siena, Italy, M. Galleni Université de Liège, Liège, Belgium, HP. Gerber Pfizer Biotherapeutics, Pearl River, NY, USA, R. Ghosh University of Texas Health Science Center at San Antonio , San Antonio, TX, USA, C. Giardina University of Connecticut, Storrs, CT, USA, O. Handa Kyoto Prefectural University of Medicine, Kyoto, Japan, K. Kashfi City University of New York (CUNY), New York, NY, USA, F.A.E. Kruyt Universitair Medisch Centrum Groningen, Groningen, Netherlands, I. Marzo Universidad de Zaragoza, Zaragoza, Spain, C. Michiels Université de Namur, Namur, Belgium, J. Neyts KU Leuven, Leuven, Belgium, S. Nock Cephalon, Inc., Redwood City, CA, USA, B.A. Ruggeri Cephalon, Inc., West Chester, PA, USA, G.L. Russo Consiglio Nazionale delle Ricerche, Avellino, Italy, K.S.M. Smalley H. Lee Moffitt Cancer Center, Tampa, FL, USA, F. Takahashi-Yanaga Kyushu University, Fukuoka, Japan, B.A. Teicher National Cancer Institute, Rockville, MD, USA, K.D. Tew Medical University of South Carolina, Charleston, SC, USA, G. Viola Università degli Studi di Padova, Padova, Italy, J. Wang Shanghai Medicilon, Inc., Shanghai, China, F. Zunino National Institute for the Study and Cure of Tumors, Milan, Italy, Cardiovascular P. Anversa Brigham and Women's Hospital, Boston, MA, USA, M.R. Bennett University of Cambridge, Cambridge, UK, Y.-H. Feng Uniformed Services University of Health Sciences, Bethesda, MD, USA, D. Fitzgerald University College Dublin, Belfield, Ireland, B.M. Frey-von Matt Universitätspoliklinik Bern, Bern, Switzerland, R.A. Khalil Harvard Medical School, W. Roxbury, MA, USA, D. Newby University of Edinburgh, Edinburgh, UK, F.G. Spinale University of South Carolina, Columbia, SC, USA, B. Staels Institut Pasteur, Lille, France, R.J. Winquist Vertex Pharmaceuticals Inc, Cambridge, MA, USA, Metabolic Disorders and Endocrinology N. Chattopadhyay Central Drug Research Institute, Lucknow, Uttar Pradesh, India, I. de Lannoy NoAb BioDiscoveries Inc., Mississauga, ON, Canada, Y. Kanai Osaka University, Suita-Shi, Japan, A. Kowluru Wayne State University, Detroit, MI, USA, J. Pierre INSERM U749, Villejuif, France, M.E. Poirot Institut Claudius Regaud, Toulouse, France, C.D. Sutherland University of Dundee, Dundee, UK, H. Yamazaki Showa Pharmaceutical University, Tokyo, Japan, Inflammation and Immunopharmacology M.J. Alcaraz Universitat de València, Valencia, Spain, R. Beyaert Universiteit Gent, Gent (Zwijnaarde), Belgium, A. Bowie Trinity College, Dublin, Ireland, M. Burczynski Bristol-Myers Squibb Co., Pennington, NJ, USA, F. D'Acquisto William Harvey Research Institute, London, UK, J. El Benna INSERM, Paris, France, M.P. Fink University of California at Los Angeles (UCLA), Los Angeles, CA, USA, K.B. Glaser Abbott Laboratories, Abbott Park, IL, USA, J.P. Hardwick Northeastern Ohio University College of Medicine, Rootstown, OH, USA, J.-H. Lai Chang Gung Memorial Hospital, Taiwan, E. Lavelle Trinity College Dublin, Dublin 2, Ireland, O. Lèo Université Libre de Bruxelles, Gosselies, Belgium, K. McCoy Virginia Commonwealth University, Richmond, VA, USA, A. Miller Carmel Med
 
 
 
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Author Services

Prepare your Article for submission
Translation Services
English Language Editing
Illustrations

Celebrate your publication success
Article Offprints, Journal Issues, Article/Cover Posters, Create Your Own Book

Additional Services
Mobile Apps,Special Content Offerings,and more...